3 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#5053 out of 5055 analysts
Average Return
-7.76%
Win Rate
37%191 out of 518
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +432.84% | $1.34 | $7.14 | 2025-04-13 - 2025-10-10 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-06 - 2020-09-14 | Buy |
Adc Therapeutics SaADCT | +287.50% | $0.80 | $3.10 | 2023-09-18 - 2024-09-18 | Buy |
Caribou Biosciences IncCRBU | +222.54% | $0.77 | $2.49 | 2025-04-27 - 2025-10-10 | Buy |
Adc Therapeutics SaADCT | +213.48% | $1.41 | $4.42 | 2025-03-30 - 2025-10-10 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Perspective Therapeutics IncCATX | 5 | Buy | $10.00 | +105.76% | Reiterates | 10 days ago |
Prelude Therapeutics IncPRLD | 17 | Buy | $5.00 | +296.83% | Reiterates | 20 days ago |
Nuvation Bio IncNUVB | 15 | Buy | $10.00 | +167.38% | Reiterates | 24 days ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $27.00 | +128.43% | Initiates Coverage On | a month ago |
Cullinan Therapeutics IncCGEM | 2 | Buy | $24.00 | +224.32% | Reiterates | a month ago |
IMMIX Biopharma IncIMMX | 9 | Buy | $8.00 | +220.00% | Maintains | a month ago |
Telix Pharmaceuticals LtdTLX | 2 | Buy | $20.00 | +108.99% | Maintains | a month ago |
Biontech SeBNTX | 43 | Buy | $136.00 | +33.25% | Reiterates | a month ago |
Onkure Therapeutics IncOKUR | 4 | Buy | $34.00 | +1,014.75% | Reiterates | 2 months ago |
Relay Therapeutics IncRLAY | 21 | Buy | $14.00 | +115.38% | Maintains | 2 months ago |
Bicara Therapeutics IncBCAX | 5 | Buy | $40.00 | +124.97% | Maintains | 2 months ago |
Oric Pharmaceuticals IncORIC | 25 | Buy | $19.00 | +38.89% | Maintains | 2 months ago |
Arrivent Biopharma IncAVBP | 11 | Buy | $42.00 | +101.34% | Maintains | 2 months ago |
Exelixis IncEXEL | 10 | Buy | $46.00 | +20.58% | Maintains | 2 months ago |
Black Diamond Therapeutics IncBDTX | 14 | Buy | $10.00 | +144.50% | Maintains | 2 months ago |
Y Mabs Therapeutics IncYMAB | 15 | Hold | $8.60 | -0.12% | Downgrades | 2 months ago |
Cogent Biosciences IncCOGT | 12 | Buy | $21.00 | +29.07% | Maintains | 2 months ago |
Cardiff Oncology IncCRDF | 3 | Buy | $10.00 | +352.49% | Maintains | 2 months ago |
Adicet Bio IncACET | 1 | Buy | $4.00 | +313.65% | Assumes | 3 months ago |
Elicio Therapeutics IncELTX | 8 | Buy | $13.00 | +22.87% | Maintains | 3 months ago |
Nurix Therapeutics IncNRIX | 16 | Buy | $34.00 | +248.36% | Maintains | 3 months ago |
Karyopharm Therapeutics IncKPTI | 1 | Buy | $27.00 | +390.91% | Assumes | 3 months ago |
Replimune Group IncREPL | 16 | Buy | $22.00 | +385.65% | Reiterates | 3 months ago |
Zymeworks IncZYME | 21 | Hold | $13.00 | -28.02% | Reiterates | 3 months ago |
Enliven Therapeutics IncELVN | 5 | Buy | $48.00 | +130.55% | Maintains | 3 months ago |
Tuhura Biosciences IncHURA | 3 | Buy | $12.00 | +402.09% | Reiterates | 5 months ago |
Revolution Medicines IncRVMD | 18 | Buy | $72.00 | +49.25% | Maintains | 5 months ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | +0.02% | Downgrades | 5 months ago |
Caribou Biosciences IncCRBU | 14 | Buy | $3.00 | +20.48% | Maintains | 5 months ago |
Tango Therapeutics IncTNGX | 12 | Buy | $13.00 | +82.07% | Reiterates | 6 months ago |
Adc Therapeutics SaADCT | 18 | Buy | $8.00 | +81.00% | Reiterates | 6 months ago |
Macrogenics IncMGNX | 18 | Hold | $2.00 | +18.34% | Maintains | 7 months ago |
Pmv Pharmaceuticals IncPMVP | 11 | Buy | $5.00 | +270.37% | Reiterates | 7 months ago |
Allogene Therapeutics IncALLO | 14 | Buy | $8.00 | +550.41% | Maintains | 7 months ago |
Repare Therapeutics IncRPTX | 18 | Buy | $5.00 | +177.78% | Maintains | 7 months ago |
Cargo Therapeutics IncCRGX | 3 | Buy | $33.00 | +638.26% | Reiterates | a year ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | a year ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | a year ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | a year ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | a year ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | a year ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | 2 years ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Alphaton Capital CorpATON | 5 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Atara Biotherapeutics IncATRA | 8 | Buy | $700.00 | N/A | Maintains | 2 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 3 years ago |
Fate Therapeutics IncFATE | 6 | Hold | $7.00 | N/A | Downgrades | 3 years ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 3 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 4 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 4 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.